Cardiotoxicity Risks of Adjuvant Trastuzumab in Asian Breast Cancer Patients.

被引：0
|
作者：
Shih, V. [1 ]
Chan, A. [1 ]
Sim, M. H. [1 ]
Teo, C. [1 ]
Chen, W. [1 ]
Wong, Z. W. [1 ]
机构：
[1] Natl Canc Ctr, Singapore, Singapore
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P2-18-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-18-05
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study
    Wadhwa, Deepa
    Fallah-Rad, Nazanin
    Grenier, Debjani
    Krahn, Marianne
    Fang, Tielan
    Ahmadie, Roien
    Walker, Jonathan R.
    Lister, Danica
    Arora, Rakesh C.
    Barac, Ivan
    Morris, Andrew
    Jassal, Davinder S.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (02) : 357 - 364
  • [22] Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
    Tarantini, Luigi
    Cioffi, Giovanni
    Gori, Stefania
    Tuccia, Fausto
    Boccardi, Lidia
    Bovelli, Daniella
    Lestuzzi, Chiara
    Maurea, Nicola
    Oliva, Stefano
    Russo, Giulia
    Faggiano, Pompilio
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (02) : 113 - 119
  • [23] Adjuvant trastuzumab for breast cancer outside of clinical trials: Cardiotoxicity and economic evaluation
    Snow, S.
    Skedgel, C.
    Rayson, D.
    Thompson, K.
    Sellon, M.
    Barnes, P.
    Jeyakumar, A.
    Younis, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study
    Deepa Wadhwa
    Nazanin Fallah-Rad
    Debjani Grenier
    Marianne Krahn
    Tielan Fang
    Roien Ahmadie
    Jonathan R. Walker
    Danica Lister
    Rakesh C. Arora
    Ivan Barac
    Andrew Morris
    Davinder S. Jassal
    Breast Cancer Research and Treatment, 2009, 117 : 357 - 364
  • [25] A population-based study of adjuvant trastuzumab-mediated cardiotoxicity among early stage HER-2+breast cancer patients.
    McArthur, H. L.
    Barnett, J.
    Chia, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S113 - S113
  • [26] Cardiotoxicity of trastuzumab adjuvant treatment in positive HER2 breast cancer
    Piotrowski, G.
    Gawor, R.
    Potemski, P.
    Gawor, Z.
    EUROPEAN HEART JOURNAL, 2013, 34 : 831 - 832
  • [27] Right Ventricular Dysfunction is Common in Patients With Breast Cancer Experiencing Cardiotoxicity During Adjuvant Trastuzumab Therapy
    Calleja, Anna
    Poulin, Frederic
    McDonald, Michael
    Delgado, Diego H.
    Thavendiranathan, Paaladinesh
    CIRCULATION, 2013, 128 (22)
  • [28] Cardiotoxicity of Trastuzumab in the adjuvant Treatment of Breast Cancer Patients Results of the NCCTG-N9831-Study
    Krug, David
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (03) : 193 - 195
  • [29] Trastuzumab related cardiotoxicity in breast cancer
    Hsieh, Hui-Hsia
    Wu, Tien-Yuan
    Chen, Chi-Hua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 371 - 372
  • [30] Long-term risk of heart failure associated with adjuvant trastuzumab in breast cancer patients.
    Goldhar, Hart Adam
    Yan, Andrew
    Ko, Dennis
    Earle, Craig
    Tomlinson, George A.
    Trudeau, Maureen E.
    Krahn, Murray
    Krzyzanowska, Monika K.
    Pal, Raveen
    Brezden, Christine B.
    Gavura, Scott
    Lien, Kelly
    Chan, Kelvin K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345